M. P. Curtis, W. Dwight, J. Pratt, M. Cowart, T. A. Esbenshade, K. M. Kruger, G. B. Fox, J. B. Pan, T. G. Pagano, A. A. Hancock, R. Faghih and Y. Bennani, “D- Amino Acid Homopiperazine Amides: Discovery of A-320436, a Potent and Selective Non-Imidazole Histamine H3-Receptor Antagonist,” Archiv der Pharmazie, Vol. 337, No. 4, 2004, pp. 219-229. doi:10.1002/ardp.200300844

has been cited by the following article:

• TITLE: Synthesis and Biological Evaluation of Novel Homopiperazine Derivatives as Anticancer Agents

  AUTHORS: Simin Teimoori, Kuppusamy Panjamurthy, Kambappa Vinaya, Doddakunche S. Prasanna, Sathees C. Raghavan, Kanchugarakoppal S. Rangappa

  KEYWORDS: Cancer Therapy, Cytotoxicity, 1, 4-Diazepane, Isocyanates, Isothiocyanates

  JOURNAL NAME: Journal of Cancer Therapy, Vol.2 No.4, October 12, 2011

  ABSTRACT: In search of new anticancer agents, a series of novel 1-benzhydryl-4-(substituted phenylcarboxamide / carbothioamide)-1,4-diazepane derivatives were designed, synthesized and characterized using 1H NMR, LCMS and elemental analysis. These molecules were evaluated for their anti-cancer activity by trypan blue exclusion and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay on B-cell leukemic cell line, Reh. Carboxamide moiety containing derivatives showed good activity compared to the corresponding carbothioamide derivatives. In particular, 4-benzhydryl-N-(3-chlorophenyl)-1,4-diazepane-1-carboxamide showed good activity with IC50 value of 18 µM.